FDA Breakthrough Designation for XCath's Iris System Highlights Potential to Expand Access to Stroke Care in India
Sep 16, 2026
New Delhi [India], September 16: XCath Robotics, a medical device company advancing endovascular surgical robotics, has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Iris Surgical Robotic System for remote robotic-assisted mechanical thrombectomy in patients with acute ischemic stroke.
Read More ..
